Published in J Pediatr on February 01, 1984
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Clinical aspects and self-reported symptoms of sequelae of Yersinia enterocolitica infections in a population-based study, Germany 2009-2010. BMC Infect Dis (2013) 0.89
Guidelines for managing acute gastroenteritis based on a systematic review of published research. Arch Dis Child (1998) 0.89
Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990. Antimicrob Agents Chemother (1994) 0.78
Foodborne Illnesses. Curr Treat Options Gastroenterol (2001) 0.78
Unique activity spectrum of colicin FY: all 110 characterized Yersinia enterocolitica isolates were colicin FY susceptible. PLoS One (2013) 0.75
Probable transmission of Yersinia enterocolitica from a pet dog with diarrhoea to a 1-year-old infant. BMJ Case Rep (2013) 0.75
Yersinia enterocolitica sepsis in a 3-week-old child. J Natl Med Assoc (1994) 0.75
Role of antimicrobials in the treatment of adult patients presenting to the emergency department with acute gastroenteritis - A mini review. Pak J Med Sci (2017) 0.75
Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol (1999) 6.60
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A (1989) 4.87
Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell (1990) 4.47
The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol (1986) 4.09
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00
Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94
Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis (1985) 3.66
The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis (1985) 3.66
5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med (1972) 3.55
Campylobacter gastroenteritis in children. J Pediatr (1979) 3.42
Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature (1999) 3.41
Serum resistance associated with virulence in Yersinia enterocolitica. Infect Immun (1982) 3.37
The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell (2000) 3.19
Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Microbiol (1993) 3.08
The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med (1990) 2.89
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med (1991) 2.79
Phenotypic tolerance: the search for beta-lactam antibiotics that kill nongrowing bacteria. Rev Infect Dis (1986) 2.75
Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74
Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73
Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrob Agents Chemother (1986) 2.68
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun (1986) 2.64
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Penicillin tolerance genes of Streptococcus pneumoniae: the ABC-type manganese permease complex Psa. Mol Microbiol (1998) 2.48
Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43
The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis (1985) 2.34
Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun (1989) 2.31
Penicillin-insensitive pneumococci. Case report and review. Am J Dis Child (1979) 2.25
Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun (1996) 2.23
Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol (2000) 2.16
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells. Infect Immun (1993) 2.09
Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04
Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99
Ribavirin: adverse drug reactions, 1986 to 1988. Pediatr Infect Dis J (1990) 1.98
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1970) 1.97
Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother (1986) 1.95
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr (1971) 1.75
Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis (1987) 1.74
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74
Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr (1981) 1.70
Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis (1987) 1.69
Ligand specificity of purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect effects of an Arg-Gly-Asp (RGD) sequence. J Immunol (1993) 1.65
Clinical manifestations of coxsackievirus infections in children. Am J Dis Child (1974) 1.62
Invasiveness of Yersinia enterocolitica lacking the virulence plasmid: an in-vivo study. J Med Microbiol (1987) 1.62
In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). Appl Microbiol (1971) 1.60
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest (1982) 1.59
Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59
Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol. Antimicrob Agents Chemother (1975) 1.58
Biosynthesis of biotin in microorganisms. VI. Further evidence for desthiobiotin as a precursor in Eschericia coli. J Bacteriol (1967) 1.50
Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors. J Bacteriol (1986) 1.48
Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med (1970) 1.48
Vitamin A levels in children with measles in Long Beach, California. J Pediatr (1992) 1.42
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum. Antimicrob Agents Chemother (1985) 1.42
Biosynthesis of biotin in microorganisms. IV. Repression and derepression of (+ -)-biotin synthesis from (+)-desthiobiotin. Arch Biochem Biophys (1966) 1.42
Identification of a Streptococcus pneumoniae gene locus encoding proteins of an ABC phosphate transporter and a two-component regulatory system. J Bacteriol (1999) 1.40
Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39
Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. Dev Biol Stand (1985) 1.39
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.37
Immunization today--a review. Can Med Assoc J (1973) 1.37
Transglycosylase and endopeptidase participate in the degradation of murein during autolysis of Escherichia coli. J Bacteriol (1986) 1.35
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr (1980) 1.34
Adverse reactions to 1975 bivalent influenza vaccine in children. Can Med Assoc J (1977) 1.34
Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3. Antimicrob Agents Chemother (1977) 1.34
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr (1981) 1.33
Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med (1984) 1.32
Passive immunization in experimental Herpesvirus hominis infection of newborn mice. Infect Immun (1975) 1.31
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30
Induction of autolysis in nongrowing Escherichia coli. J Bacteriol (1986) 1.29
The histopathology of rectosigmoid biopsies from adults with bloody diarrhea due to verotoxin-producing Escherichia coli. Am J Clin Pathol (1987) 1.29
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Meningococcal colonization and infection in children and their household contacts. Am J Epidemiol (1979) 1.27
Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. J Clin Invest (1992) 1.27
The glomerulopathy of congenital syphilis--an immune deposit disease. J Pediatr (1972) 1.27
In vitro activity of BMY-28100 against common isolates from pediatric infections. Antimicrob Agents Chemother (1987) 1.26
Oral antibiotic therapy of skeletal infections in children. Pediatrics (1980) 1.23
Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin. Mol Cell (2000) 1.23
Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae. J Infect Dis (1991) 1.23
Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr (Phila) (1993) 1.21
Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr (1992) 1.20
Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect (2000) 1.20
Piracy of adhesins: attachment of superinfecting pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis. Infect Immun (1986) 1.20
The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis (1988) 1.20
Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19
Biosynthesis of desthiobiotin in cell-free extracts of Escherichia coli. J Bacteriol (1969) 1.19
Rapid identification of herpes simplex virus in tissue culture by direct immunofluorescence. J Lab Clin Med (1971) 1.19
Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological media. Appl Microbiol (1970) 1.18
Exchange transfusion in the treatment of hepatic coma. J Pediatr (1969) 1.18
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis (2001) 1.18
Risk factors for Escherichia coli O157:H7 infection in an urban community. J Infect Dis (1989) 1.18
Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus. J Pediatr (1978) 1.18
Biosynthesis of biotin in microorganisms. V. Control of vitamer production. J Bacteriol (1967) 1.17
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17
Single-dose pharmacokinetics of aztreonam in pediatric patients. Antimicrob Agents Chemother (1984) 1.16